Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
Clinical trial NCT03219476 · COMPLETED
Trial details
- NCT number
- NCT03219476
- Sponsor
- Medical College of Wisconsin
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-05
- Primary completion
- 2020-02-04
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.